Estrologo, Danilo F.

HRN: 21-45-45  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2023
CEFTAZIDIME 1GM (VIAL)
01/02/2023
01/22/2023
IVT
1g
Q8
Community Acquired Pneumonia
Waiting Final Action 

Indication:  EmpiricEmpirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: